Abstract:It seems inherently improbable that an academic researcher can ask and answer a clinical question that matters to a patient. The US health care system is in disarray. Our medical research juggernaut is assaulted on all sides by concerns about federal financing, corporate loyalties (and royalties), and translating research into clinical practice. We spend billions of dollars, conduct more clinical trials, and obtain more “outcomes.” But it seems like no one really gets any better. There seems to be a major disconnect between academic multicenter, rigorous protocol-driven Phase III trials and actual community life and clinical practice. Treatments and guidelines rigorously studied at the academic health center frequently fail to make it into every day clinical practice or individual patient life. Practice-based research and community-oriented primary care both seek to take research out of the academic medical center into the community, and while successful, their approach may only be half right. Community-based participatory research (CBPR) may be one approach to help us out of the mess we’re in. CBPR links the researcher and the individual community member in a manner that will dramatically change both. Patients spend their time living their lives, not hanging out at a medical office. Most medical care is chosen and acted on by the patient living in his/ her own personal or community context. Individuals decide when to access professional medical care, what to believe about their medical diagnosis and treatment, what over-the-counter medication to take, what supplement or complementary care to obtain, and how and when to take their prescribed treatments. Really, it is the ordinary citizen that distills all the available medical knowledge and translates it into his/her own life. Not to include them in the production of that knowledge is a grave disservice and severely limits our research findings. CBPR may be an important element of practice redesign in the coming decade to assure that changes in the clinical office reflect the needs of patients. Participatory research should be an essential element in the NIH Roadmap that seeks to quickly and efficiently link medical problem to medical researcher, and back to the patient. CBPR gives traction to ideas that have been percolating in clinical primary care research for the last century. Julie Stevenson and the Robert Wood Johnson Foundation Prescription for Health Program have put together an outstanding annotated bibliography on the history and recent advances in CBPR, available through the STFM Family Medicine Digital Resources Library at http://www.fmdrl.org/879. CBPR has moved from the fringe of clinical research to become a standard, widely accepted research method. This annotated bibliography provides a single document to assist the novice in beginning his/her own work in CBPR. It provides the seasoned researcher with a wealth of information on successes, failures, and outcomes in participatory research. This manuscript has distilled the more than 100 articles about CBPR into a quintessential primer on participatory research. This work is not a metaanalysis, nor is it an exhaustive list of all the articles published on CBPR. The success of CBPR would make that undertaking nearly impossible, and certainly unreadable. The Agency for Healthcare Research and Quality has provided a comprehensive literature review on CBPR. This work really is a guided tour, describing the state-of-the-art in CBPR. Ms Stevenson serves as the docent on this tour and covers major themes, definitions, policies, guidelines, evidence, and insights on CBPR. This manuscript could serve as the core reading list for an introductory curriculum on CBPR. The benefit of participatory research goes far beyond the simple notion of asking a patient what he/she thinks about a research idea. Participatory research occurs in the community, where people live their lives, and live their medical care. Participatory research allows for studying the process of wellness and illness, the manner in which individuals seek diagnosis and treatment, the interplay between patient and health care provider or institution. It is in participatory research where what matters to the common folk bubbles up to the clinical trial, where the act of living one’s life is inextricably connected to living one’s health, and where that interface between a patient’s daily life and health care’s greatest aim can be explored and medical care improved. Use this annotated bibliography. Keep a copy on your desk. Read the papers cited within. Practice participation. Discover good things.

The regulatory action of the myxobacterial CarD/CarG complex: a bacterial enhanceosome?

The Impact of Serum Cystatin C on Short Term Prognosis in Petients With Ischemic Heart Failure

Serum Cystatin C is Associated with Renal Function Recovery in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

Elevated serum cystatin C at continuous renal replacement therapy initiation predicts lack of renal recovery.

Cystatin C in Prediction of Acute Kidney Injury: A Systemic Review and Meta-analysis

Elevated Serum Cystatin C is an Independent Predictor of Cardiovascular Events in People with Relatively Normal Renal Function

Elevated Serum Cystatin C at Continuous Renal Replacement Therapy Initiation Predicts Lack of Renal Recovery

Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease

Serum Cystatin C is a Potential Endogenous Marker for the Estimation of Renal Function in Male Gout Patients with Renal Impairment

Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function

Measurements of the fracture energy of lithiated silicon electrodes of Li-ion batteries.

#767 Utility of cystatin C as a predictor for postoperative acute kidney injury in non-cardiac surgeries [S1]

Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease

Pretransplant Renal Function Evaluated by Serum Cystatin C Was Associated with Mortality after Liver Transplantation: a Single-Center Experience

Serum Cystain C As a New Marker for the Estimation of Glomerular Filtration Rate in Peritoneal Dialysis Patients

Cystatin C-Based Renal Function in Predicting the Long-Term Outcomes of Chronic Total Occlusion After Percutaneous Coronary Intervention

Relations Between Markers of Renal Function, Coronary Risk Factors and the Occurrence and Severity of Coronary Artery Disease

Prognostic Value of Cystatin C-Derived Estimated Glomerular Filtration Rate in Patients with Acute Heart Failure

A GUIDED TOUR OF COMMUNITY-BASED PARTICIPATORY RESEARCH: AN ANNOTATED BIBLIOGRAPHY

Cystatin C is Better than Serum Creatinine for Estimating Glomerular Filtration Rate to Detect Osteopenia in Chronic Kidney Disease Patients

Serum cystatin C is a potential predictor of short-term mortality and acute kidney injury in acute aortic dissection patients: a retrospective cohort study